Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: A randomised, open-label, multicentre, phase 3 trial

Patrick Schöffski, Sant Chawla, Robert G. Maki, Antoine Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Camargo, Sebastian Bauer, Sun Young Rha, Jean Yves Blay, Peter Hohenberger, David D'Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D. Demetri, Shreyaskumar R. Patel

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: A randomised, open-label, multicentre, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences